Posts Tagged ‘sizes’

Lilly CEO sizes up challenges, lessons learned
Brand-name drug makers are facing unprecedented challenges: legal challenges from pharmacies alleging price fixing, generic drugs eating into company profits and government regulation threatening to crimp operations.